Lumbard & Kellner’s Celgene Corp CELG Stock Holding History

Lumbard & Kellner’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-50,210	Closed	-$69K	–	101
2014 Q2	$69K	Buy	+50,210	New	+$3.82M	0.05%	74

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Lumbard & Kellner's CELG Position: Q3 2014 in Review

Lumbard & Kellner sold out of Celgene Corp (CELG) in Q3 2014, closing a stake of 50,210 shares — an estimated $69K sold.

Lumbard & Kellner first reported a position in CELG in Q2 2014 and held it in 1 quarter. The position peaked at $69K in Q2 2014. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

Lumbard & Kellner reported no remaining Celgene Corp position as of Q3 2014 after selling out during the quarter.
Lumbard & Kellner sold 50,210 Celgene Corp shares in Q3 2014, an estimated $69K.
Lumbard & Kellner first reported a position in Celgene Corp in Q2 2014 and held it in 1 quarter.
Lumbard & Kellner's Celgene Corp position peaked at $69K in Q2 2014.
1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Lumbard & Kellner's 13F filing for Q3 2014, filed 14 Nov 2014.